- Illumina announced an agreement to acquire SomaLogic on September 3, 2025, utilizing SomaLogic's technology for new assays.
- Illumina acquired SomaLogic for cash and royalties.
Standard BioTools acquired SomaLogic, retaining reagent rights for Illumina, following a strategic sale of SomaLogic to Illumina.
1 report, 0 independent
Updated Jun 23
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Standard BioTools acquired SomaLogic, retaining reagent rights for Illumina, following a strategic sale of SomaLogic to Illumina.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Illumina
American company that develops systems for the analysis of genetic variation
-
SomaLogic
company in Boulder, United States
Nothing else this week.
-
Standard BioTools Inc.
company in South San Francisco, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- Unknown outlet